Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megha L Mehrotra

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
The Journal of Infectious Diseases|August 28, 2015
Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell ActivationPeter J Kuebler, Megha L Mehrotra, Brian I Shaw, et al.
The Journal of Infectious Diseases|November 16, 2023
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus PlaceboPaul N Zivich, Stephen R Cole, Jessie K Edwards, et al.
AIDS (London, England)|December 4, 2019
HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular healthSimon B Ascher, Rebecca Scherzer, Michelle M Estrella, et al.
Open Forum Infectious Diseases|August 11, 2021
SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in CaliforniaKatherine Lamba, Heather Bradley, Kayoko Shioda, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 2, 2021
Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARICKan Z Gianattasio, Erin E Bennett, Jingkai Wei, et al.
The Journal of Infectious Diseases|April 3, 2025
Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or ZinlirvimabJoseph J Eron, Paul P Cook, Megha L Mehrotra, et al.
Open Forum Infectious Diseases|July 20, 2022
CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021-July 2021Megha L Mehrotra, Esther Lim, Katherine Lamba, et al.
BMC Medical Research Methodology|May 27, 2024
CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online surveyEsther Lim, Megha L Mehrotra, Katherine Lamba, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trialPeter J Kuebler, Megha L Mehrotra, J Jeff McConnell, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
The Journal of Infectious Diseases|August 28, 2015
Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell ActivationPeter J Kuebler, Megha L Mehrotra, Brian I Shaw, et al.
The Journal of Infectious Diseases|November 16, 2023
HIV Prevention Among Men Who Have Sex With Men: Tenofovir Alafenamide Combination Preexposure Prophylaxis Versus PlaceboPaul N Zivich, Stephen R Cole, Jessie K Edwards, et al.
AIDS (London, England)|December 4, 2019
HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular healthSimon B Ascher, Rebecca Scherzer, Michelle M Estrella, et al.
Open Forum Infectious Diseases|August 11, 2021
SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in CaliforniaKatherine Lamba, Heather Bradley, Kayoko Shioda, et al.
AIDS and Behavior|April 30, 2016
The Effect of Depressive Symptoms on Adherence to Daily Oral PrEP in Men who have Sex with Men and Transgender Women: A Marginal Structural Model Analysis of The iPrEx OLE StudyMegha L Mehrotra, David V Glidden, Vanessa McMahan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 2, 2021
Generalizability of findings from a clinical sample to a community-based sample: A comparison of ADNI and ARICKan Z Gianattasio, Erin E Bennett, Jingkai Wei, et al.
The Journal of Infectious Diseases|April 3, 2025
Lenacapavir Plus Two Broadly Neutralizing Antibodies, Teropavimab and Zinlirvimab, for People With HIV-1 Highly Susceptible to Either Teropavimab or ZinlirvimabJoseph J Eron, Paul P Cook, Megha L Mehrotra, et al.
Open Forum Infectious Diseases|July 20, 2022
CalScope: Monitoring Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence From Vaccination and Prior Infection in Adults and Children in California May 2021-July 2021Megha L Mehrotra, Esther Lim, Katherine Lamba, et al.
BMC Medical Research Methodology|May 27, 2024
CalScope: methodology and lessons learned for conducting a remote statewide SARS-CoV-2 seroprevalence study in California using an at-home dried blood spot collection kit and online surveyEsther Lim, Megha L Mehrotra, Katherine Lamba, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 2015
Cellular immune correlates analysis of an HIV-1 preexposure prophylaxis trialPeter J Kuebler, Megha L Mehrotra, J Jeff McConnell, et al.
Pageof 3